Cancer drugmaker G1 Therapeutics raised $105 million in an IPO last night, the latest development in a recent uptick of biotech offerings.
G1, of Research Triangle Park, NC, sold 7 million shares at $15 apiece. G1 had to sell more shares... Read more »
Cybersecurity company Proofpoint, which helped slow the sweeping global ransomware attack WannaCry after it emerged Friday, has now discovered a much more insidious, profitable, and potentially widespread cyberattack called Adylkuzz.
Adylkuzz doesn’t demand, as WannaCry does, that victims pay a ransom... Read more »
This may be the incident that finally pushes ransomware into the mainstream—and also forces both organizations and malicious hackers to adapt their approaches when it comes to this type of attack.
The “WannaCry” virus, which first hit companies and healthcare services... Read more »
[Updated 5/18/17, 4:01 pm. See below.] Manure is an inescapable part of farming, and it can be an expensive and messy one at that. Large animal farms produce so much waste that it must be stored in tall piles... Read more »
On a day dominated by news about President Trump’s firing of FBI director James Comey, and its impact on the ongoing investigation of Russian hacking of the 2016 presidential election, two significant developments for the cybersecurity industry also emerged Thursday.
First,... Read more »
“New York, New York, it’s a hell of a town. The Bronx is up, but we’re Brooklyn down.”
For all you old-school Brooklyn swingers out there, we’ll take a short break from the madness in the nation’s capital and start... Read more »
Scott Gottlieb will be the new FDA commissioner.
The U.S. Senate voted 57 to 42 on Tuesday to confirm Gottlieb, a physician and venture capitalist, to lead the regulatory agency. He succeeds former FDA commissioner Robert Califf, who stepped down in... Read more »
Two dramatic healthcare stories played out this week. First, to the jubilation of the nation’s science community, Congress proposed to boost National Institutes of Health funding, not slash it as the Trump administration had outlined. Then the patchwork revival of the... Read more »
In a survey of 29 Silicon Valley venture capitalists in December, the VCs mulled whether President-elect Donald Trump would buoy up their investment prospects with lower corporate taxes and government regulations, or worsen conditions by heightening global political instability and raising... Read more »